comparemela.com

Latest Breaking News On - Ochsner cancer institute - Page 1 : comparemela.com

Gulf South Clinical Trials Network Named a Spoke in the ARPA-H Customer Experience Catalyst Hub

Gulf South Clinical Trials Network Named a Spoke in the ARPA-H Customer Experience Catalyst Hub
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Mississippi
United-states
New-orleans
Louisiana
Alabama
Americans
Augusto-ochoa
Ochsner-cancer-institute
Feist-weiler-cancer-center-ochsner
Gulf-south-clinical-trials-network
Health-shreveport
Health-new-orleans

La. Cancer Centers Join Network to Increase Access to Clinical Trials

La. Cancer Centers Join Network to Increase Access to Clinical Trials
bizneworleans.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizneworleans.com Daily Mail and Mail on Sunday newspapers.

United-states
Alabama
Louisiana
Mississippi
New-orleans
Americans
Augusto-ochoa
Health-shreveport
Health-new-orleans
Gulf-south-clinical-trials-network
National-cancer-institute
Feist-weiler-cancer-center-ochsner

Cancer centers' masking approaches vary in wake of viruses' resurgence

Cancer centers across the country are facing the challenge of independently deciding on masking policies during the COVID-19 pandemic.

Maryland
United-states
Catherine-liu
John-greene
Fred-hutch
Anne-gross
Donna-berizzi
Zoe-larned
Dana-farber-cancer-institute
Moffitt-cancer-center
Ochsner-cancer-institute
Fred-hutchinson-cancer-center

Moonlight and Miracles gala honors Gayle Benson

The 11th annual Moonlight and Miracles, presented by the Gayle and Tom Benson Foundation, took place Nov. 3 at the Caesars Superdome.

Gayle-benson
Suma-reddy-satti
Tom-benson-foundation
Ochsner-cancer-institute
Ochsner-health
John-curtis-christian-school
Blue-rhythm
Ochsner-cancer
Society

PARP Inhibition Changes Individualized Treatment in Advanced Ovarian Cancer

The addition of PARP inhibitors for the treatment of patients with BRCA-mutated advanced ovarian cancer has provided clinicians with a stronger set of treatment options. Looking at how the BRCA mutation responds to these inhibitors is then vital to deciding the patient’s treatment path.

United-states
Texas
Louisiana
Chad
New-orleans
California
American
Dilip-solanki
Lars-neumann
Los-angeles
End-results-program
National-cancer-institute

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.